藥物成份

共有 21098 個藥物成份

FLECAINIDE ACETATE

• 關聯藥證數量: 1

FLORAD

• 關聯藥證數量: 1

FLOW-COUNT Fluorospheres consists of 10 um (nomial diameter) polystyrene fluorospheres in an aqueous suspension medium containing a surfactant and 1% formaldehyde. Each fluorospheres contains a dye which has a fluorescence emission range of 525 nm to 700 nm when excited at 488 nm. The Assayed Concentration of FLOW-COUNT Fluorospheres is derived from multiple replicate analyses on a COULTER ZBI particles analyzer.

• 關聯藥證數量: 1

FLUCONAZOLE (C13H12F2N6O) Content：99.0 per cent to 101.0 per cent (dried substance).

• 關聯藥證數量: 1

FLUCYTOSINE

• 關聯藥證數量: 1

FLUID EXTRACT GLYCYRRHIZA

• 關聯藥證數量: 1

FLUMAZENIL

• 關聯藥證數量: 1

FLUMEQUINE

• 關聯藥證數量: 1

FLUOCORTOLONE (TRIMETHYL ACETATE)

• 關聯藥證數量: 1

FLUONILID

• 關聯藥證數量: 1

FLUORESCEIN (SODIUM)

• 關聯藥證數量: 1

FLUOROURACIL 5- (SODIUM)

• 關聯藥證數量: 1

FLUPENTIXOL (EQ TO FLUPENTHIXOL)

• 關聯藥證數量: 1

FLUPENTIXOL CIS-DECANOATE (EQ TO FLUPENTHIXOL CIS-DECANOATE)

• 關聯藥證數量: 1

FLUPHENAZINE

• 關聯藥證數量: 1

FLUPREDNIDENE 21-ACETATE

• 關聯藥證數量: 1

FLURAZEPAM (HCL)

• 關聯藥證數量: 1

FLUROPREDNISOLONE 9-ALPHA 21-ACETATE

• 關聯藥證數量: 1

FLUROPREDNISOLONE 9-ALPHA 21-PHOSPHATE (SODIUM)

• 關聯藥證數量: 1

FLUSPIRILENE

• 關聯藥證數量: 1

FLUTAMIDE

• 關聯藥證數量: 1

FLUTEMETAMOL (18F)

• 關聯藥證數量: 1

FOLIC ACID (YEAST CONC.)

• 關聯藥證數量: 1

FOLIC ACID ANHYDROUS

• 關聯藥證數量: 1

FOLIC ACID HYDRATE

• 關聯藥證數量: 1

FOLINIC ACID

• 關聯藥證數量: 1

FOLLICLE STIM HORMONE-RF HUMAN

• 關聯藥證數量: 1

FOLLICLE STIMULATE HORMONE

• 關聯藥證數量: 1

FOLLIDCULI SENNAE POWDER

• 關聯藥證數量: 1

FOMOCAINE HCL

• 關聯藥證數量: 1

FONAZINE (MESYLATE)

• 關聯藥證數量: 1

FONDAPARINUX SODIUM

• 關聯藥證數量: 1

FOOD PIGMENT RED NO6

• 關聯藥證數量: 1

FORMALDEHYDE

• 關聯藥證數量: 1

FORMALDEHYDE PARA-

• 關聯藥證數量: 1

FORMOTEROL FUMARATE HYDATE

• 關聯藥證數量: 1

FOSAPREPITANT DIMEGLUMINE

• 關聯藥證數量: 1

FOSFOMYCIN TROMETAMOL

• 關聯藥證數量: 1

FPSA Flex reagent cartridge:\nWellsa Form Ingredient Concentrationb Source\n1 Liquid PSA 0.09 mg/moL Mouse, \n Ab-β-galactosidasec monoclonal\n2 Liquid Chrome dilient 4.8 mg/mL \n3 Tabletd Antibody-CrO2c 1.8 mg/mL Mouse,\n monoclonal\n4,5, 6 Tabletsd CPRG 10.3 mg/mL \n7 Liquid CPRG diluent 42 mg/mL \na. Wells are numbered consecutively from the wide end of the cartridge.\nb. Nominal value in hydrated cartridge.\nc. Antibody titer and conjugate activity may vary from lot to lot.\nd. Tablets contain excipients, buffers, and stabilizers.

• 關聯藥證數量: 1

FRAGRANCE

• 關聯藥證數量: 1

FRANDIOMYCIN SULFATE

• 關聯藥證數量: 1

FRANGULA CORTEX EXTRACT

• 關聯藥證數量: 1

FRUCTOSE ANHYDRATE

• 關聯藥證數量: 1

FRUCTOSE DIPHOSPHATE CALCIUM SALT

• 關聯藥證數量: 1

FRUCTRUS SABAL EXT.

• 關聯藥證數量: 1

FRUCTUS ALKEKENGI

• 關聯藥證數量: 1

FRUCTUS ROSAE CANINAE

• 關聯藥證數量: 1

FSH Reagent: FSH Test Units: Each barcode-labeled unit contains one bead coated with monoclonal murine anti-FSH. \nFSH Reagent Wedge: alkaline phosphatase (bovine calf intestine) conjugated to murine monoclonal anti-FSH antibody in buffer, with preservative. \nFSH Adjustors: Two vials (Low and High), of FSH in a nonhuman serum matrix, with preservative.\nFSH Sample Diluent: an FSH-free nonhuman serum matrix, with preservative.

• 關聯藥證數量: 1

FSH Standards:One vial, 2.0 mL, labeled A, containing 0 mIU/mL and six vials, 1.0 mL each, labeled B-G, containing concentrations of approximately 1.5, 4.5, 15.0, 45.0, 150.0 and 450.0 mIU/mL FSH (from human pituitary gland) in porcine serum with sodium azide as a preservative.*DSL-4700 (500 Tubes) contains three sets of calibrators.Anti-FSH [I-125] Reagent:One vial, 11 mL each, containing < 10 μCi (370 kBq) of [I-125]-labeled anti-FSH in a protein-based (BSA) buffer with sodium azide as a preservative.*DSL-4700 (500 Tubes) contains five vials of reagent.Anti-FSH-Coated Tubes:One hundred (100) plastic tubes or five hundred plastic tubes with anti-FSH antibody immobilized to the inside wall of each tube. FSH Controls:Two vials, 1.0 mL each, levels I and II, containing low and high concentrations of FSH (from human pituitary gland) in porcine serum with sodium azide as a preservative.Wash Concentrate:One bottle, 100 mL, containing wash concentrate with sodium azide as a preservative.*DSL-4700 (500 Tubes) contai

• 關聯藥證數量: 1

FUCUTASE

• 關聯藥證數量: 1

FUJI DRI-CHEM CONTROL L LEVEL QP-L is prepared from pooled human serum and a base matrix via freeze-drying.\nAnimal-derived enzyme components are added to QP-L for some enzyme tests.

• 關聯藥證數量: 1

FUKUTASE

• 關聯藥證數量: 1

FULVESTRANT

• 關聯藥證數量: 1

FUMARIAE HERBA

• 關聯藥證數量: 1

FUMARIC ACID

• 關聯藥證數量: 1

FUNGUS ENZYME

• 關聯藥證數量: 1

FURALTADINE HCL

• 關聯藥證數量: 1

FUSIDIC ACID ( AS HEMIHYDRATE )

• 關聯藥證數量: 1

Factor Deficient Plasma IX:\nLyophilized human plasma that has been depleted of the specific factor; contains stabilizers.

• 關聯藥證數量: 1

Factor II Deficient Human Plasma

• 關聯藥證數量: 1

Factor IX Deficient Human Plasma

• 關聯藥證數量: 1

Factor IX deficient plasma: 5 x 1 mL vials of lyophilized human plasma that has been antificially depleted of factor IX containing buffer and stabilizers.

• 關聯藥證數量: 1

Factor V Deficient Human Plasma

• 關聯藥證數量: 1

Factor VII Deficient Human Plasma

• 關聯藥證數量: 1

Factor VIII Deficient Human Plasma.　

• 關聯藥證數量: 1

Factor VIII deficient plasma：lyophilized human plasma that has been artificially depleted of factor VIII containing buffer and stabilizers.

• 關聯藥證數量: 1

Factor X Deficient Human Plasma

• 關聯藥證數量: 1

Factor X deficient plasma：5x1 mL vials of lyophilized human plasma that has been artificially depleted of factor X containing buffer and stabilizers.

• 關聯藥證數量: 1

Factor XI Deficient Human Plasma

• 關聯藥證數量: 1

Factor XII Deficient Human Plasma

• 關聯藥證數量: 1

Factor XII deficient plasma: 5 x 1 mL vials of lyophilized human plasma deficient in factor XII (immunodepleted/congenital mixture) containing buffer and stabilizers.

• 關聯藥證數量: 1

Factor Xa Reagent: lyophilized; human plasma fraction with the additives Tris (6 g/L), sodium chloride (12 g/L) and EDTA (0.74 g/L)Dextran Sulfate Reagent, lyophilized; concentration in the working solution: 0.02 g/LAT III Reagent (human), lyophilized; concentration in the working solution: 1 IU/mLSubstrate Reagent, lyophilized; concentration in the working solution: 4 mmol/L Z-D-leu-gly-arg-ANBA-methyl amide

• 關聯藥證數量: 1

Factor Xa Reagent：4 vials. Each vial contains approximately 20 nKat freeze-dried bovine factor Xa and 0.02% Sodium Azide.\nAntithrombin III：4 vials. Each vial contains freeze-dried Human Antithrombin III and buffer salts, which upon reconstitution yield 0.05M Tris HCl, 0.175M NaCl, 7.5mM EDTA, pH 8.4 and 0.44% Sodium Azide.\nFactor Xa Substrate：4 vials. Each vial contains 4 μ moles freeze-dried\nMeO-CO-D-CHG-Gly-Arg-pNA.

• 關聯藥證數量: 1

Famciclovir contains not less than 98.0% and not more than 102.0% of C14H19N5O4, calculated on dried basis.

• 關聯藥證數量: 1

Famotidine contains 98.5%~101.0% of C8H15N7O2S3 (dried basis.)

• 關聯藥證數量: 1

Famotidine contains not less than 98.5 percent and not more than 101.0 percent of C8H15H7O2S3, calculated on the dried basis.

• 關聯藥證數量: 1

Famotidine contains not less than 98.5% and not more than 101.0% of C8H15N7O2S3, calculated on the dried basis.

• 關聯藥證數量: 1

Famotidine contains not less than 98.5% and not more than 101.0% of C8H15N7O2S3, calculated on the dried basis.

• 關聯藥證數量: 1

Famotidine contains not less than 98.5% and not more than 101.5% of C8H15N7O2S3, calculated on the dried substance.

• 關聯藥證數量: 1

Fe standard (200ug/dL)

• 關聯藥證數量: 1

Fe/IBCT-CALIBRATOR 1 CONSTITUENTS CONCENTRATIONHydrochloric Acid 0.10 mmol/LFe/IBCT-CALIBRATOR 2 CONSTITUENTS CONCENTRATIONFerric Chloride 35.8 μmol/LHydrochloric Acid 0.10 mmol/L

• 關聯藥證數量: 1

Febuxostat (Form A)

• 關聯藥證數量: 1

Febuxostat (Form A) contains not less than 98.0% and not more than 102.0% of C16H16N2O3S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Febuxostat (Form-A) contains not less than 98.0% and not more than 102.0% of C16H16N2O3S, calculated on the dried basis.

• 關聯藥證數量: 1

Febuxostat (Form-G) contains not less than 98.0% and not more than 102.0% of C16H16O3N2S‧1/2H2O, calculated on anhydrous basis.

• 關聯藥證數量: 1

Febuxostat contains not less than 98.0 percent and not more than 102.0 percent of C16H16N2O3S, calculated on anhydrous substance.

• 關聯藥證數量: 1

Febuxostat contains not less than 98.0% and not more than 102.0% of C16H16N2O3S (on dried basis.)

• 關聯藥證數量: 1

Febuxostat contains not less than 98.0% and not more than 102.0% of C16H16N2O3S, calculated on the dried basis.

• 關聯藥證數量: 1

Febuxostat contains not less than 98.0% and not more than 102.0% of C16H16N2O3S, calculated on anhydrous substance.

• 關聯藥證數量: 1

Febuxostat contains not less than 98.0% and not more than 102.0% of C16H16N2O3S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Febuxostat contains not less than 98.0% and not more than 102.0% of C16H16N2O3S, calculated on the dried basis.

• 關聯藥證數量: 1

Febuxostat contains not less than 98.0% and not more than 102.0%, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Febuxostat hemihydrate

• 關聯藥證數量: 1

Febuxostat hemihydrate contains NLT 98.0% and NMT 102.0% of C16H16N2O3S．1/2 H2O, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Felodipine contains not less than 98.0% and not more than 101.0% of C18H19Cl2NO4 calculated on dried basis.

• 關聯藥證數量: 1

Felodipine contains not less than 98.0% and not more than101.0% of C18H19C12NO4,calculated on the dried basis.

• 關聯藥證數量: 1

Fenbufen contains not less than 98.5% and not more than the equivalent of 101.0% of 4-(biphenyl-4-yl)-4-oxobutanoic acid, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Fenbufen contains not less than 98.5% and of C16H14O3,calculated with reference to the dried substance

• 關聯藥證數量: 1

Fenofibrate contains not less than 98.0% and not more than 102.0% of C20H21ClO4, calculated on the dried substance.

• 關聯藥證數量: 1

Fenofibrate contains not less than 98.5 percent and not more than 101.0 percent of C20H21ClO4, calculated with reference to the dried substance.

• 關聯藥證數量: 1